Paper22012269
Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
Van Regenmortel MH. Arch Virol, 2012. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine. Papers, record 22012269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22012269
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Antigens, Viral | Major topic |
| Drug Design | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Animals | |
| Epitopes | |
| Humans |
Source PubMed
References207
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2427937 | Comparison of different methods for localizing antigenic regions in histone H2A. | Mol Immunol | 1986 | https://conductscience.org/library/papers/2427937 | PubMed |
| 2 | 15795308 | Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. | J Virol | 2005 | https://conductscience.org/library/papers/15795308 | PubMed |
| 3 | 17418361 | Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. | Virology | 2007 | https://conductscience.org/library/papers/17418361 | PubMed |
| 4 | 7973652 | Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. | Science | 1994 | https://conductscience.org/library/papers/7973652 | PubMed |
| 5 | 19552398 | HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D. | Biochemistry | 2009 | https://conductscience.org/library/papers/19552398 | PubMed |
| 6 | 1993848 | Binding to native proteins by antipeptide monoclonal antibodies. | J Immunol | 1991 | https://conductscience.org/library/papers/1993848 | PubMed |
| 7 | 17409160 | Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. | J Virol | 2007 | https://conductscience.org/library/papers/17409160 | PubMed |
| 8 | 11698650 | Degeneracy and complexity in biological systems. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11698650 | PubMed |
| 9 | 2441250 | Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies. | Mol Immunol | 1987 | https://conductscience.org/library/papers/2441250 | PubMed |
| 10 | 15036900 | From interception to incorporation: degeneracy and promiscuous recognition as precursors of a paradigm shift in immunology. | Mol Immunol | 2004 | https://conductscience.org/library/papers/15036900 | PubMed |
| 11 | 2416848 | Theoretical considerations of the ability of monoclonal antibodies to detect antigenic differences between closely related variants, with particular reference to heterospecific reactions. | J Immunol Methods | 1985 | https://conductscience.org/library/papers/2416848 | PubMed |
| 12 | 7692082 | A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. | J Virol | 1993 | https://conductscience.org/library/papers/7692082 | PubMed |
| 13 | 12089434 | Diversity considerations in HIV-1 vaccine selection. | Science | 2002 | https://conductscience.org/library/papers/12089434 | PubMed |
| 14 | 21233310 | A therapeutic dendritic cell-based vaccine for HIV-1 infection. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21233310 | PubMed |
| 15 | 15607824 | Degeneracy, mimicry and crossreactivity in immune recognition. | Mol Immunol | 2005 | https://conductscience.org/library/papers/15607824 | PubMed |
| 16 | 10368281 | Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. | Structure | 1999 | https://conductscience.org/library/papers/10368281 | PubMed |
| 17 | 12447900 | Reductionism and the search for structure-function relationships in antibody molecules. | J Mol Recognit | 2002 | https://conductscience.org/library/papers/12447900 | PubMed |
| 18 | 7941328 | Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody binding, and neutralization. | Virology | 1994 | https://conductscience.org/library/papers/7941328 | PubMed |
| 19 | 13789973 | Immunological speculations. | Annu Rev Microbiol | 1960 | https://conductscience.org/library/papers/13789973 | PubMed |
| 20 | 15247456 | Outstanding questions on HIV vaccine trial. | Science | 2004 | https://conductscience.org/library/papers/15247456 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33780441 | Using the antibody-antigen binding interface to train image-based deep neural networks for antibody-epitope classification. | PLoS Comput Biol | 2021 | https://conductscience.org/library/papers/33780441 | PubMed |
| 31921119 | Using Omics Technologies and Systems Biology to Identify Epitope Targets for the Development of Monoclonal Antibodies Against Antibiotic-Resistant Bacteria. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921119 | PubMed |
| 29546103 | Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine? | AIMS Public Health | 2015 | https://conductscience.org/library/papers/29546103 | PubMed |
| 29387066 | Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design. | Front Immunol | 2017 | https://conductscience.org/library/papers/29387066 | PubMed |
| 28944092 | MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA. | J Vaccines Vaccin | 2017 | https://conductscience.org/library/papers/28944092 | PubMed |
| 27657055 | Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27657055 | PubMed |
| 27458032 | Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking. | Front Immunol | 2016 | https://conductscience.org/library/papers/27458032 | PubMed |
| 26344344 | Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens. | Vaccines (Basel) | 2013 | https://conductscience.org/library/papers/26344344 | PubMed |
| 26157442 | Editorial: Paradigm Changes are Required in HIV Vaccine Research. | Front Immunol | 2015 | https://conductscience.org/library/papers/26157442 | PubMed |
| 25477882 | An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine. | Front Immunol | 2014 | https://conductscience.org/library/papers/25477882 | PubMed |
| 25210191 | Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits. | J Virol | 2014 | https://conductscience.org/library/papers/25210191 | PubMed |
| 24033298 | Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1. | Curr HIV Res | 2013 | https://conductscience.org/library/papers/24033298 | PubMed |
| 23866844 | Development of prophylactic vaccines against HIV-1. | Retrovirology | 2013 | https://conductscience.org/library/papers/23866844 | PubMed |
| 23227445 | Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design. | J AIDS Clin Res | 2012 | https://conductscience.org/library/papers/23227445 | PubMed |
| 23089396 | Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine. | J Immunol | 2012 | https://conductscience.org/library/papers/23089396 | PubMed |
| 22912636 | Controlling the HIV/AIDS epidemic: current status and global challenges. | Front Immunol | 2012 | https://conductscience.org/library/papers/22912636 | PubMed |
| 22787464 | Basic research in HIV vaccinology is hampered by reductionist thinking. | Front Immunol | 2012 | https://conductscience.org/library/papers/22787464 | PubMed |
| 22546090 | Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies. | BMC Res Notes | 2012 | https://conductscience.org/library/papers/22546090 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22012269
GET https://conductscience.org/api/papers/v1/22012269/references?page=2